168 related articles for article (PubMed ID: 38085441)
1. Transforming growth factors β and their signaling pathway in renal cell carcinoma and peritumoral space-transcriptome analysis.
Kajdaniuk D; Hudy D; Strzelczyk JK; Młynarek K; Słomian S; Potyka A; Szymonik E; Strzelczyk J; Foltyn W; Kos-Kudła B; Marek B
Clin Transl Oncol; 2024 May; 26(5):1229-1239. PubMed ID: 38085441
[TBL] [Abstract][Full Text] [Related]
2. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
4. [The profile of expression of transforming growth factor beta1 and TGFbetaRI, TGFbetaRII and TGFbetaRIII genes in nasal polyps].
Rostkowska-Nadolska B; Kapral M; Mazurek U; Gawron W; Bochnia M; Preś K
Otolaryngol Pol; 2007; 61(6):944-50. PubMed ID: 18546940
[TBL] [Abstract][Full Text] [Related]
5. Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.
Mangone FR; Walder F; Maistro S; Pasini FS; Lehn CN; Carvalho MB; Brentani MM; Snitcovsky I; Federico MH
Mol Cancer; 2010 May; 9():106. PubMed ID: 20462450
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
[TBL] [Abstract][Full Text] [Related]
7. Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta.
Baugé C; Cauvard O; Leclercq S; Galéra P; Boumédiene K
Arthritis Res Ther; 2011 Feb; 13(1):R23. PubMed ID: 21324108
[TBL] [Abstract][Full Text] [Related]
8. Intracellular dynamics of Smad-mediated TGFbeta signaling.
Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
[TBL] [Abstract][Full Text] [Related]
9. TGFβ/Smad signalling in psoriatic epidermis models exposed to salt water soaks and narrowband ultraviolet B radiation.
Gambichler T; Terras S; Skrygan M
Cytokine; 2013 Oct; 64(1):35-8. PubMed ID: 23838545
[TBL] [Abstract][Full Text] [Related]
10. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
11. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Wang WM; Liu F; Chen N
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
Goumans MJ; Mummery C
Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
[TBL] [Abstract][Full Text] [Related]
13. Uncoordinated regulation of mRNA expression of the three isoforms of transforming growth factor-beta in the mouse skin carcinogenesis model.
Rundhaug JE; Park J; Fischer SM
Mol Carcinog; 1997 Feb; 18(2):115-26. PubMed ID: 9049187
[TBL] [Abstract][Full Text] [Related]
14. TGFβ splicing and canonical pathway activation in high-grade serous carcinoma.
Gutgold N; Davidson B; Catane LJ; Holth A; Hellesylt E; Tropé CG; Dørum A; Reich R
Virchows Arch; 2017 Jun; 470(6):665-678. PubMed ID: 28432432
[TBL] [Abstract][Full Text] [Related]
15. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
16. Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor.
Kodama S; Podyma-Inoue KΑ; Uchihashi T; Kurioka K; Takahashi H; Sugauchi A; Takahashi K; Inubushi T; Kogo M; Tanaka S; Watabe T
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296292
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
18. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
19. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, and TGFbeta3) during embryonic rat testis development.
Cupp AS; Kim G; Skinner MK
Biol Reprod; 1999 Jun; 60(6):1304-13. PubMed ID: 10330085
[TBL] [Abstract][Full Text] [Related]
20. Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway.
Walker L; Millena AC; Strong N; Khan SA
Clin Exp Metastasis; 2013 Jan; 30(1):13-23. PubMed ID: 22678424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
